Zhen Zhong, Xunyan Ouyang, Qicai Guo, Li Xiong, Xianfa Liu
{"title":"[核因子 E2 相关因子 2 蛋白通过调节铁蛋白沉积介导脓毒症相关肝损伤】。]","authors":"Zhen Zhong, Xunyan Ouyang, Qicai Guo, Li Xiong, Xianfa Liu","doi":"10.3760/cma.j.cn121430-20231105-00941","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To investigate the effect of nuclear factor E2-related factor 2 (Nrf2) protein on ferroptosis in mice with sepsis-associated liver injury (SALI).</p><p><strong>Methods: </strong>he male Sprague-Dawley (SD) mice were divided into 6 groups according to the random number table method, with 6 mice in each group. The SALI model of mice was established by cecal ligation and puncture (CLP), and the Sham group was only treated with laparotomy. CLP+Fer-1 group, CLP+Erastin group, CLP+ML385 group and CLP+Curcumin group were intraperitoneally injected with iron death inhibitor Ferrostatin-1 (Fer-1) 10 mg×kg<sup>-1</sup>×d<sup>-1</sup>, iron death activator Erastin 20 mg×kg<sup>-1</sup>×d<sup>-1</sup>, Nrf2 inhibitor ML385 30 mg×kg<sup>-1</sup>×d<sup>-1</sup> and Nrf2 activator Curcumin 100 mg×kg<sup>-1</sup>×d<sup>-1</sup> after CLP, respectively; Sham group and CLP group were given normal saline 10 mg×kg<sup>-1</sup>×d<sup>-1</sup>, each group was administered continuously for 10 days. Ten days after operation, the serum and liver tissues of mice were collected to detect the levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in serum, and the levels of malondialdehyde (MDA), glutathione (GSH) and Fe<sup>2</sup><sup>+</sup>; in liver homogenate. The pathological changes of liver tissue were observed under light microscope after hematoxylin-eosin (HE) staining. The shape and length of mitochondria in liver cells were observed under transmission electron microscope. The protein expressions of Nrf2, glutathione peroxidase 4 (GPX4) and prostaglandin-endoperoxide synthase 2 (PTGS2) in liver tissue were detected by Western blotting.</p><p><strong>Results: </strong>Compared with Sham group, the serum levels of ALT and AST in the CLP group were significantly increased; histologically, the hepatic cord was disordered, the cells were swollen and necrotic, and the length of mitochondria was significantly shortened; the levels of MDA and Fe<sup>2</sup><sup>+</sup> in liver tissue increased significantly, and the content of GSH decreased significantly; the protein expressions of Nrf2 and GPX4 in liver tissue decreased, and the protein expression of PTGS2 increased significantly. Compared with CLP group, the serum levels of ALT and AST in CLP+Fer-1 group and CLP+Curcumin group were significantly decreased [ALT (U/L): 80.65±19.44, 103.45±20.52 vs. 283.50±37.12, AST (U/L): 103.33±11.90, 127.33±15.79 vs. 288.67±36.82, all P < 0.05]; microscopically, the hepatic cord was irregular, the cells were slightly swollen, and the mitochondrial length was significantly increased (μm: 1.42±0.09, 1.43±0.21 vs. 1.07±0.25, both P < 0.05); the levels of MDA and Fe<sup>2</sup><sup>+</sup>; in liver tissue decreased significantly, and the content of GSH increased significantly [MDA (mol/g): 0.87±0.23, 1.85±0.43 vs. 4.47±0.95, Fe<sup>2</sup><sup>+</sup> (μg/g): 63.80±7.15, 67.48±6.28 vs. 134.52±14.32, GSH (mol/g): 1.95±0.29, 1.95±0.45 vs. 0.55±0.29, all P < 0.05]; the protein expressions of Nrf2 and GPX4 in liver tissue were significantly increased, and the protein expression of PTGS2 was significantly decreased (Nrf2/GAPDH: 1.80±0.28, 2.10±0.43 vs. 0.70±0.24, GPX4/GAPDH: 0.80±0.06, 0.93±0.07 vs. 0.48±0.02, PTGS2/GAPDH: 0.76±0.05, 0.84±0.01 vs. 1.02±0.09, all P < 0.05). However, the results of the above indexes in the CLP+Erastin group and CLP+ML385 group were opposite, and the serum levels of ALT and AST were significantly increased [ALT (U/L): 344.52±40.79, 321.70±21.10 vs. 283.50±37.12, AST (U/L): 333.50±27.90, 333.00±16.67 vs. 288.67±36.82, all P < 0.05]; microscopically, the arrangement of hepatic cords was disordered, the cells were obviously swollen and necrotic, and the length of mitochondria was significantly shortened (μm: 0.78±0.13, 0.67±0.07 vs. 1.07±0.25, both P < 0.05); the levels of MDA and Fe<sup>2</sup><sup>+</sup> in liver tissue increased significantly, and the content of GSH decreased significantly [MDA (mol/g): 5.92±1.06, 5.62±0.56 vs. 4.47±0.95, Fe<sup>2</sup><sup>+</sup> (μg/g): 151.40±8.03, 151.88±8.68 vs. 134.52±14.32, GSH (mol/g): 0.25±0.08, 0.23±0.11 vs. 0.55±0.29, all P < 0.05]; the protein expressions of Nrf2 and GPX4 in liver tissue were significantly decreased, and the protein expression of PTGS2 was significantly increased (Nrf2/GAPDH: 0.46±0.09, 0.46±0.11 vs. 0.70±0.24, GPX4/GAPDH: 0.34±0.05, 0.40±0.01 vs. 0.48±0.02, PTGS2/GAPDH: 1.24±0.13, 1.16±0.11 vs. 1.02±0.09, all P < 0.05).</p><p><strong>Conclusions: </strong>CLP-induced SALI can lead to ferroptosis in mice hepatocytes, and Nrf2 protein in liver tissue can mediate SALI by regulating ferroptosis.</p>","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Nuclear factor E2-related factor 2 protein mediates sepsis-associated liver injury by regulating ferroptosis].\",\"authors\":\"Zhen Zhong, Xunyan Ouyang, Qicai Guo, Li Xiong, Xianfa Liu\",\"doi\":\"10.3760/cma.j.cn121430-20231105-00941\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To investigate the effect of nuclear factor E2-related factor 2 (Nrf2) protein on ferroptosis in mice with sepsis-associated liver injury (SALI).</p><p><strong>Methods: </strong>he male Sprague-Dawley (SD) mice were divided into 6 groups according to the random number table method, with 6 mice in each group. The SALI model of mice was established by cecal ligation and puncture (CLP), and the Sham group was only treated with laparotomy. CLP+Fer-1 group, CLP+Erastin group, CLP+ML385 group and CLP+Curcumin group were intraperitoneally injected with iron death inhibitor Ferrostatin-1 (Fer-1) 10 mg×kg<sup>-1</sup>×d<sup>-1</sup>, iron death activator Erastin 20 mg×kg<sup>-1</sup>×d<sup>-1</sup>, Nrf2 inhibitor ML385 30 mg×kg<sup>-1</sup>×d<sup>-1</sup> and Nrf2 activator Curcumin 100 mg×kg<sup>-1</sup>×d<sup>-1</sup> after CLP, respectively; Sham group and CLP group were given normal saline 10 mg×kg<sup>-1</sup>×d<sup>-1</sup>, each group was administered continuously for 10 days. Ten days after operation, the serum and liver tissues of mice were collected to detect the levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in serum, and the levels of malondialdehyde (MDA), glutathione (GSH) and Fe<sup>2</sup><sup>+</sup>; in liver homogenate. The pathological changes of liver tissue were observed under light microscope after hematoxylin-eosin (HE) staining. The shape and length of mitochondria in liver cells were observed under transmission electron microscope. The protein expressions of Nrf2, glutathione peroxidase 4 (GPX4) and prostaglandin-endoperoxide synthase 2 (PTGS2) in liver tissue were detected by Western blotting.</p><p><strong>Results: </strong>Compared with Sham group, the serum levels of ALT and AST in the CLP group were significantly increased; histologically, the hepatic cord was disordered, the cells were swollen and necrotic, and the length of mitochondria was significantly shortened; the levels of MDA and Fe<sup>2</sup><sup>+</sup> in liver tissue increased significantly, and the content of GSH decreased significantly; the protein expressions of Nrf2 and GPX4 in liver tissue decreased, and the protein expression of PTGS2 increased significantly. Compared with CLP group, the serum levels of ALT and AST in CLP+Fer-1 group and CLP+Curcumin group were significantly decreased [ALT (U/L): 80.65±19.44, 103.45±20.52 vs. 283.50±37.12, AST (U/L): 103.33±11.90, 127.33±15.79 vs. 288.67±36.82, all P < 0.05]; microscopically, the hepatic cord was irregular, the cells were slightly swollen, and the mitochondrial length was significantly increased (μm: 1.42±0.09, 1.43±0.21 vs. 1.07±0.25, both P < 0.05); the levels of MDA and Fe<sup>2</sup><sup>+</sup>; in liver tissue decreased significantly, and the content of GSH increased significantly [MDA (mol/g): 0.87±0.23, 1.85±0.43 vs. 4.47±0.95, Fe<sup>2</sup><sup>+</sup> (μg/g): 63.80±7.15, 67.48±6.28 vs. 134.52±14.32, GSH (mol/g): 1.95±0.29, 1.95±0.45 vs. 0.55±0.29, all P < 0.05]; the protein expressions of Nrf2 and GPX4 in liver tissue were significantly increased, and the protein expression of PTGS2 was significantly decreased (Nrf2/GAPDH: 1.80±0.28, 2.10±0.43 vs. 0.70±0.24, GPX4/GAPDH: 0.80±0.06, 0.93±0.07 vs. 0.48±0.02, PTGS2/GAPDH: 0.76±0.05, 0.84±0.01 vs. 1.02±0.09, all P < 0.05). However, the results of the above indexes in the CLP+Erastin group and CLP+ML385 group were opposite, and the serum levels of ALT and AST were significantly increased [ALT (U/L): 344.52±40.79, 321.70±21.10 vs. 283.50±37.12, AST (U/L): 333.50±27.90, 333.00±16.67 vs. 288.67±36.82, all P < 0.05]; microscopically, the arrangement of hepatic cords was disordered, the cells were obviously swollen and necrotic, and the length of mitochondria was significantly shortened (μm: 0.78±0.13, 0.67±0.07 vs. 1.07±0.25, both P < 0.05); the levels of MDA and Fe<sup>2</sup><sup>+</sup> in liver tissue increased significantly, and the content of GSH decreased significantly [MDA (mol/g): 5.92±1.06, 5.62±0.56 vs. 4.47±0.95, Fe<sup>2</sup><sup>+</sup> (μg/g): 151.40±8.03, 151.88±8.68 vs. 134.52±14.32, GSH (mol/g): 0.25±0.08, 0.23±0.11 vs. 0.55±0.29, all P < 0.05]; the protein expressions of Nrf2 and GPX4 in liver tissue were significantly decreased, and the protein expression of PTGS2 was significantly increased (Nrf2/GAPDH: 0.46±0.09, 0.46±0.11 vs. 0.70±0.24, GPX4/GAPDH: 0.34±0.05, 0.40±0.01 vs. 0.48±0.02, PTGS2/GAPDH: 1.24±0.13, 1.16±0.11 vs. 1.02±0.09, all P < 0.05).</p><p><strong>Conclusions: </strong>CLP-induced SALI can lead to ferroptosis in mice hepatocytes, and Nrf2 protein in liver tissue can mediate SALI by regulating ferroptosis.</p>\",\"PeriodicalId\":24079,\"journal\":{\"name\":\"Zhonghua wei zhong bing ji jiu yi xue\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Zhonghua wei zhong bing ji jiu yi xue\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3760/cma.j.cn121430-20231105-00941\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Zhonghua wei zhong bing ji jiu yi xue","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3760/cma.j.cn121430-20231105-00941","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
摘要
目的方法:将雄性Sprague-Dawley(SD)小鼠按随机数字表法分为6组,每组6只。通过盲肠结扎和穿刺(CLP)建立小鼠 SALI 模型,Sham 组仅进行开腹手术。CLP+Fer-1组、CLP+Erastin组、CLP+ML385组和CLP+姜黄素组在CLP后分别腹腔注射铁死亡抑制剂Ferrostatin-1(Fer-1)10 mg×kg-1×d-1、铁死亡激活剂Erastin 20 mg×kg-1×d-1、Nrf2抑制剂ML385 30 mg×kg-1×d-1和Nrf2激活剂姜黄素100 mg×kg-1×d-1;Sham 组和 CLP 组给予生理盐水 10 mg×kg-1×d-1,每组连续给药 10 天。术后 10 天,采集小鼠血清和肝组织,检测血清中丙氨酸氨基转移酶(ALT)和天门冬氨酸氨基转移酶(AST)的水平,以及肝匀浆中丙二醛(MDA)、谷胱甘肽(GSH)和 Fe2+ 的水平。经苏木精-伊红(HE)染色后,在光镜下观察肝组织的病理变化。透射电子显微镜观察肝细胞线粒体的形状和长度。用 Western 印迹法检测肝组织中 Nrf2、谷胱甘肽过氧化物酶 4(GPX4)和前列腺素内过氧化物合成酶 2(PTGS2)的蛋白表达:结果:与Sham组相比,CLP组血清ALT、AST水平明显升高;组织学上,肝索紊乱,细胞肿胀坏死,线粒体长度明显缩短;肝组织中MDA、Fe2+水平明显升高,GSH含量明显降低;肝组织中Nrf2、GPX4蛋白表达降低,PTGS2蛋白表达明显升高。与CLP组相比,CLP+Fer-1组和CLP+姜黄素组血清ALT和AST水平明显下降[ALT(U/L):80.65±19.44、103.45±20.52 vs. 283.50±37.12,AST(U/L):103.33±11.90、127.33±15.79 vs. 288.67±36.82,均P<0.05];显微镜下,肝索不规则,细胞轻度肿胀,线粒体长度明显增加(μm:1.42±0.09,1.43±0.21 vs. 1.07±0.25,均P<0.05);肝组织中MDA、Fe2+;水平明显下降,GSH含量明显增加[MDA(mol/g):0.87±0.23, 1.85±0.43 vs. 4.47±0.95,Fe2+ (μg/g):63.80±7.15, 67.48±6.28 vs. 134.52±14.32, GSH (mol/g):1.95±0.29,1.95±0.45 vs. 0.55±0.29,均P<0.05];肝组织中Nrf2、GPX4蛋白表达量明显升高,PTGS2蛋白表达量明显降低(Nrf2/GAPDH:1.80±0.28、2.10±0.43 vs. 0.70±0.24,GPX4/GAPDH:0.80±0.06、0.93±0.07 vs. 0.48±0.02,PTGS2/GAPDH:0.76±0.05、0.84±0.01 vs. 1.02±0.09,均P<0.05)。但CLP+Erastin组与CLP+ML385组上述指标结果相反,血清ALT、AST水平明显升高[ALT(U/L):344.52±40.79、321.70±21.10 vs. 283.50±37.12,AST(U/L):333.50±27.90、333.00±16.67 vs. 288.67±36.82,均P<0.05];镜检可见肝索排列紊乱,细胞明显肿胀坏死,线粒体长度明显缩短(μm:0.78±0.13,0.67±0.07 vs. 1.07±0.25,均P<0.05);肝组织中MDA、Fe2+水平明显升高,GSH含量明显降低[MDA(mol/g):5.92±1.06, 5.62±0.56 vs. 4.47±0.95,Fe2+ (μg/g):151.40±8.03, 151.88±8.68 vs. 134.52±14.32, GSH (mol/g):0.25±0.08,0.23±0.11 vs. 0.55±0.29,均P<0.05];肝组织中Nrf2、GPX4蛋白表达量明显降低,PTGS2蛋白表达量明显升高(Nrf2/GAPDH:0.46±0.09、0.46±0.11 vs. 0.70±0.24,GPX4/GAPDH:0.34±0.05、0.40±0.01 vs. 0.48±0.02,PTGS2/GAPDH:1.24±0.13、1.16±0.11 vs. 1.02±0.09,均P<0.05):结论:CLP诱导的SALI可导致小鼠肝细胞的铁突变,肝组织中的Nrf2蛋白可通过调节铁突变介导SALI。
[Nuclear factor E2-related factor 2 protein mediates sepsis-associated liver injury by regulating ferroptosis].
Objective: To investigate the effect of nuclear factor E2-related factor 2 (Nrf2) protein on ferroptosis in mice with sepsis-associated liver injury (SALI).
Methods: he male Sprague-Dawley (SD) mice were divided into 6 groups according to the random number table method, with 6 mice in each group. The SALI model of mice was established by cecal ligation and puncture (CLP), and the Sham group was only treated with laparotomy. CLP+Fer-1 group, CLP+Erastin group, CLP+ML385 group and CLP+Curcumin group were intraperitoneally injected with iron death inhibitor Ferrostatin-1 (Fer-1) 10 mg×kg-1×d-1, iron death activator Erastin 20 mg×kg-1×d-1, Nrf2 inhibitor ML385 30 mg×kg-1×d-1 and Nrf2 activator Curcumin 100 mg×kg-1×d-1 after CLP, respectively; Sham group and CLP group were given normal saline 10 mg×kg-1×d-1, each group was administered continuously for 10 days. Ten days after operation, the serum and liver tissues of mice were collected to detect the levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in serum, and the levels of malondialdehyde (MDA), glutathione (GSH) and Fe2+; in liver homogenate. The pathological changes of liver tissue were observed under light microscope after hematoxylin-eosin (HE) staining. The shape and length of mitochondria in liver cells were observed under transmission electron microscope. The protein expressions of Nrf2, glutathione peroxidase 4 (GPX4) and prostaglandin-endoperoxide synthase 2 (PTGS2) in liver tissue were detected by Western blotting.
Results: Compared with Sham group, the serum levels of ALT and AST in the CLP group were significantly increased; histologically, the hepatic cord was disordered, the cells were swollen and necrotic, and the length of mitochondria was significantly shortened; the levels of MDA and Fe2+ in liver tissue increased significantly, and the content of GSH decreased significantly; the protein expressions of Nrf2 and GPX4 in liver tissue decreased, and the protein expression of PTGS2 increased significantly. Compared with CLP group, the serum levels of ALT and AST in CLP+Fer-1 group and CLP+Curcumin group were significantly decreased [ALT (U/L): 80.65±19.44, 103.45±20.52 vs. 283.50±37.12, AST (U/L): 103.33±11.90, 127.33±15.79 vs. 288.67±36.82, all P < 0.05]; microscopically, the hepatic cord was irregular, the cells were slightly swollen, and the mitochondrial length was significantly increased (μm: 1.42±0.09, 1.43±0.21 vs. 1.07±0.25, both P < 0.05); the levels of MDA and Fe2+; in liver tissue decreased significantly, and the content of GSH increased significantly [MDA (mol/g): 0.87±0.23, 1.85±0.43 vs. 4.47±0.95, Fe2+ (μg/g): 63.80±7.15, 67.48±6.28 vs. 134.52±14.32, GSH (mol/g): 1.95±0.29, 1.95±0.45 vs. 0.55±0.29, all P < 0.05]; the protein expressions of Nrf2 and GPX4 in liver tissue were significantly increased, and the protein expression of PTGS2 was significantly decreased (Nrf2/GAPDH: 1.80±0.28, 2.10±0.43 vs. 0.70±0.24, GPX4/GAPDH: 0.80±0.06, 0.93±0.07 vs. 0.48±0.02, PTGS2/GAPDH: 0.76±0.05, 0.84±0.01 vs. 1.02±0.09, all P < 0.05). However, the results of the above indexes in the CLP+Erastin group and CLP+ML385 group were opposite, and the serum levels of ALT and AST were significantly increased [ALT (U/L): 344.52±40.79, 321.70±21.10 vs. 283.50±37.12, AST (U/L): 333.50±27.90, 333.00±16.67 vs. 288.67±36.82, all P < 0.05]; microscopically, the arrangement of hepatic cords was disordered, the cells were obviously swollen and necrotic, and the length of mitochondria was significantly shortened (μm: 0.78±0.13, 0.67±0.07 vs. 1.07±0.25, both P < 0.05); the levels of MDA and Fe2+ in liver tissue increased significantly, and the content of GSH decreased significantly [MDA (mol/g): 5.92±1.06, 5.62±0.56 vs. 4.47±0.95, Fe2+ (μg/g): 151.40±8.03, 151.88±8.68 vs. 134.52±14.32, GSH (mol/g): 0.25±0.08, 0.23±0.11 vs. 0.55±0.29, all P < 0.05]; the protein expressions of Nrf2 and GPX4 in liver tissue were significantly decreased, and the protein expression of PTGS2 was significantly increased (Nrf2/GAPDH: 0.46±0.09, 0.46±0.11 vs. 0.70±0.24, GPX4/GAPDH: 0.34±0.05, 0.40±0.01 vs. 0.48±0.02, PTGS2/GAPDH: 1.24±0.13, 1.16±0.11 vs. 1.02±0.09, all P < 0.05).
Conclusions: CLP-induced SALI can lead to ferroptosis in mice hepatocytes, and Nrf2 protein in liver tissue can mediate SALI by regulating ferroptosis.